Get Real Time Here
| Open10.600 | Close14.870 |
| Vol / Avg.712.593K / 3.997K | Mkt Cap30.964M |
| Day Range10.320 - 16.200 | 52 Wk Range8.465 - 42.000 |
vTv Therapeutics Stock (NASDAQ:VTVT), Quotes and News Summary
vTv Therapeutics Stock (NASDAQ: VTVT) stock price, news, charts, stock research, profile.
| Open10.600 | Close14.870 |
| Vol / Avg.712.593K / 3.997K | Mkt Cap30.964M |
| Day Range10.320 - 16.200 | 52 Wk Range8.465 - 42.000 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.080 | ||||||
| REV | 0 |
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.070 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-03-07 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 6.00 |
| 2022-08-17 | Northland Capital Markets | Carl Byrnes | Maintains | Outperform | Raises | 1.50 | 2.00 |
| 2022-02-18 | Cantor Fitzgerald | Charles Duncan | Initiates Coverage On | Overweight | Announces | - | 5.00 |
| 2020-02-10 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Raises | 5.00 | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| VTVT | vTv Therapeutics | 61.53% | 31M |
| GLTO | Galecto | -0.02% | 16.3M |
| CLRB | Cellectar Biosciences | -1.79% | 21.8M |
| LUMO | Lumos Pharma | -8.31% | 21.8M |
| EVAX | Evaxion Biotech | -2.51% | 21.6M |
How do I buy vTv Therapeutics (VTVT) stock?
You can purchase shares of vTv Therapeutics (NASDAQ: VTVT) through any online brokerage.
Who are vTv Therapeutics's (VTVT) competitors?
Other companies in vTv Therapeutics’s space includes: Galecto (NASDAQ:GLTO), Cellectar Biosciences (NASDAQ:CLRB), Lumos Pharma (NASDAQ:LUMO), Evaxion Biotech (NASDAQ:EVAX) and Sensei Biotherapeutics (NASDAQ:SNSE).
What is the target price for vTv Therapeutics (VTVT) stock?
The latest price target for vTv Therapeutics (NASDAQ: VTVT) was reported by HC Wainwright & Co. on Tuesday, March 7, 2023. The analyst firm set a price target for 6.00 expecting VTVT to fall to within 12 months (a possible -60.53% downside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for vTv Therapeutics (VTVT)?
The stock price for vTv Therapeutics (NASDAQ: VTVT) is $15.2 last updated Today at November 30, 2023 at 12:21 AM UTC.
Does vTv Therapeutics (VTVT) pay a dividend?
There is no dividend information for vTv Therapeutics.
When is vTv Therapeutics (NASDAQ:VTVT) reporting earnings?
vTv Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is vTv Therapeutics (VTVT) going to split?
There is no upcoming split for vTv Therapeutics.
What sector and industry does vTv Therapeutics (VTVT) operate in?
vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.